The top after-market NASDAQ stock market gainers are: Spectrum Pharmaceuticals, First Place Financial, Cytokinetics, Photronics, FX Energy, Ultralife, Healthways, Rodman & Renshaw Capital Group, optionsXpress Holdings, and SuperMedia.

Spectrum Pharmaceuticals, Inc. (SPPI) surged 9.98 percent to $5.95 in the after-market trading. The company said its ZEVALIN drug showed positive results in the first phase 2 clinical trail to treat patients with a type of cancer called follicular non-Hodgkin's lymphoma

Spectrum said the drug achieved a one-year overall complete response rate of 53 percent in the first Phase 2 clinical trial evaluating ZEVALIN injection for intravenous use as a monotherapy. The response rate was similar to rates reported in previous trials evaluating standard chemotherapy alone, or chemotherapy followed by ZEVALIN, in non-Hodgkin's lymphoma.

First Place Financial Corp. (FPFC) soared 5.52 percent to $2.29 in the after-hours session. The company said it plans to amend its Form 10-K for the fiscal 2010 and to restate its results of operations and financial condition for fiscal 2010.

First Place Financial expects fiscal 2010 net loss to increase to about $45.2 million or $2.98 a share from $31.2 million or $2.14 a share. As a result of changes, the company sees first quarter loss of about $740,000 or 4 cents a share. The company expects continued strong performances from net interest income and mortgage banking to drive earnings when asset quality improves in future quarters.

Cytokinetics Inc. (CYTK) improved 5.16 percent to $2.65 in the after-market trading.

Photronics Inc. (PLAB) jumped 3.20 percent to $7.10 in the after-hours session. The company's fourth quarter adjusted profit was $8.5 million or 14 cents a share, compared to a loss of $3.2 million or 7 cents a share last year. Sales rose 16 percent to $110 million. Analysts had expected profit of 13 cents a share on revenue of $114.4 million.

Photronics expects to see strong demand at the leading edge for both integrated circuits and flat panel displays at least through the first half of fiscal 2011.

FX Energy Inc. (FXEN) climbed 3.12 percent to $6.95 in the after-market trading.

Ultralife Corp. (ULBI) grew 3.01 percent to $6.85 in the after-hours session.

Healthways Inc. (HWAY) gained 3.00 percent to $10.30 in the after-market trading. The company said it reached a final settlement with The Centers for Medicare and Medicaid Services associated with its participation in both of its Medicare Health Support programs, which ran for three years from 2005 through 2008.

As a result of the settlement, the company would record revenues of $22.3 million and would refund $28.0 million from its contract billings in excess of earned revenues balance sheet account during the fourth quarter of 2010.

Healthways increased its fiscal 2010 earnings guidance to range of $1.36 to $1.43 a share from previous forecast of $1.12 to $1.19 a share. The company raised its revenue outlook to range of $717 million to $730 million from previous range of $695 million to $708 million. The company still expects adjusted earnings of $1.07 to $1.14 a share. Analysts expect profit of $1.11 a share on revenue of $699.57 million.

Rodman & Renshaw Capital Group, Inc. (RODM) increased 2.89 percent to $2.49 in the after-hours session.

optionsXpress Holdings, Inc. (OXPS) rose 2.79 percent to $20.63 in the after-market trading. The stock has reached its 2-year high of $20.46 during Monday's regular trading.

SuperMedia Inc. (SPMD) moved up 2.63 percent to $6.24 in the after-hours session.

NASDAQ Stock Market Cancer Lymphoma Cancer